论文部分内容阅读
有结直肠癌家族史者罹患结直肠癌的危险性提高。为评价化学粪隐血试验(Haemoccult,HO)和免疫粪隐血试验(Hemeseleet,HS)对筛选这些高危者的作用,作者对212例有结直肠癌家族史者进行了HO和HS检测。 实验分两组:第1组125人,具有高危家族史(一级亲属中两人或以上患结直肠癌,或一级亲属患病时<50岁),全部于结肠镜检查之前作HO和HS检测;第2组87人,均有低危家族史
Patients with a family history of colorectal cancer have increased risk of colorectal cancer. To evaluate the role of Haemoccult (HO) and Hemeseleet (HS) screening for these high-risk individuals, the authors performed HO and HS tests on 212 patients with a family history of colorectal cancer. The experiment was divided into two groups: the first group consisted of 125 people and had a high-risk family history (two or more first-degree relatives had colorectal cancer, or the first-degree relative was <50 years old), all before the colonoscopy for HO and HS test; 87 patients in group 2, all have a low-risk family history